We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GENRUI BIOTECH INC.
New
Gold Supplier
POC Analyzer
Epithod 616
New
Gold Supplier
SARS-CoV-2 Assay
SARS-CoV-2 UTAB FS
COVID-19 Anitibody Test
TGS COVID-19 IgG
SARS-CoV-2 & Influenza Test
cobas SARS-CoV-2 & Influenza A/B Test
Visit expo >

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
18 Mar 2021 - 21 Mar 2021
13 Apr 2021 - 16 Apr 2021

Image: Rapid Molecular Diagnostic Platform Sends Precise COVID-19 RNA Results to Smartphone in Minutes (Photo courtesy of Purdue University/Chris Adam)

Rapid Molecular Diagnostic Platform Sends Precise COVID-19 RNA Results to Smartphone in Minutes

An all new technology can detect COVID-19 RNA in saliva through newly developed electronic nanosensors, which significantly reduces error rates associated with chemical-based home tests. More...
05 Mar 2021
Image: Allplex SARS-CoV-2 Master Assay (Photo courtesy of Seegene, Inc.)

Seegene's Latest COVID-19 Test Simultaneously Targets Four SARS-CoV-2 Genes and Recognizes Multiple Virus Variants

Seegene, Inc. (Seoul, Korea) has finished the development of the world's first-ever variant diagnostic test that can simultaneously detect COVID-19 and screen multiple virus variants, with a single multiplex real-time PCR testing. More...
05 Mar 2021
Image: The Atellica CH 930 Immunoassay & Clinical Chemistry Analyzer (Photo courtesy of Siemens Healthcare).

Fibrinogen to Albumin Ratio Reflects ANCA‐Associated Vasculitis Activity

Microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) belong to a group of anti-neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV). More...
04 Mar 2021
Image: The Atellica CH 930 Immunoassay & Clinical Chemistry Analyzer (Photo courtesy of Siemens Healthcare).

Fibrinogen to Albumin Ratio Reflects ANCA‐Associated Vasculitis Activity

Microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) belong to a group of anti-neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV). More...
04 Mar 2021
Image: Histopathologic image from a patient with Li Fraumeni syndrome showing accumulation of mutant TP53 in tumoral cells (Photo courtesy of Thierry Soussi, PhD).

Clinical Germline Testing Evaluated for Pediatric Cancer Patients

Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have found heritable germline predisposition in 8%–12% of patients. More...
04 Mar 2021
Image: Histopathologic image from a patient with Li Fraumeni syndrome showing accumulation of mutant TP53 in tumoral cells (Photo courtesy of Thierry Soussi, PhD).

Clinical Germline Testing Evaluated for Pediatric Cancer Patients

Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have found heritable germline predisposition in 8%–12% of patients. More...
04 Mar 2021
Illustration

Mindray and Tencent AI Lab to Jointly Develop AI Products for Blood Disease Screening and In Vitro Diagnosis

Shenzhen Mindray Biomedical Electronics Co., Ltd. (Shenzhen, China) has signed an AI cooperation framework agreement with Tencent AI Lab (Shenzhen, China) to jointly develop AI products for blood cell analysis and further explore AI technology in vitro diagnostics. More...
04 Mar 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.